Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

Robert E.J. Ryder; Katharina Laubner; Marek Benes; Martin Haluzik; Lynne Munro; Harry Frydenberg; Julian P. Teare; Aruchuna Ruban; Sigal Fishman; Erwin Santo; Rainer Stengel; Charlotte De Jonge; Jan W. Greve; Ricardo V. Cohen; Cristina M. Aboud; Gerald J. Holtmann; Graeme Rich; Jess J. McMaster; Tadej Battelino; Primoz Kotnik; James P. Byrne; John C. Mason; Justin Bessell; Jeanine Bascomb; Lillian Kow; Janes Collins; Jacob Chisholm; Peter N. Pferschy; Harald Sourij; Melissa L. Cull; Melanie C. Wyres; Russell Drummond; Barbara McGowan; Stephanie A. Amiel; Mahi Yadagiri; Piya Sen Gupta; Jens Aberle; Jochen Seufert

doi:10.2337/dc22-1952

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

Robert E.J. Ryder^*, Katharina Laubner, Marek Benes, Martin Haluzik, Lynne Munro, Harry Frydenberg, Julian P. Teare, Aruchuna Ruban, Sigal Fishman, Erwin Santo, Rainer Stengel, Charlotte De Jonge, Jan W. Greve, Ricardo V. Cohen, Cristina M. Aboud, Gerald J. Holtmann, Graeme Rich, Jess J. McMaster, Tadej Battelino, Primoz KotnikJames P. Byrne, John C. Mason, Justin Bessell, Jeanine Bascomb, Lillian Kow, Janes Collins, Jacob Chisholm, Peter N. Pferschy, Harald Sourij, Melissa L. Cull, Melanie C. Wyres, Russell Drummond, Barbara McGowan, Stephanie A. Amiel, Mahi Yadagiri, Piya Sen Gupta, Jens Aberle, Jochen Seufert

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e89-e91
Journal	Diabetes Care
Volume	46
Issue number	4
DOIs	https://doi.org/10.2337/dc22-1952
State	Published - Apr 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc22-1952

Cite this

Ryder, R. E. J., Laubner, K., Benes, M., Haluzik, M., Munro, L., Frydenberg, H., Teare, J. P., Ruban, A., Fishman, S., Santo, E., Stengel, R., De Jonge, C., Greve, J. W., Cohen, R. V., Aboud, C. M., Holtmann, G. J., Rich, G., McMaster, J. J., Battelino, T., ... Seufert, J. (2023). Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide. Diabetes Care, 46(4), e89-e91. https://doi.org/10.2337/dc22-1952

@article{3844ced11f3f42d0ba41bc2d7f280fb1,

title = "Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide",

author = "Ryder, {Robert E.J.} and Katharina Laubner and Marek Benes and Martin Haluzik and Lynne Munro and Harry Frydenberg and Teare, {Julian P.} and Aruchuna Ruban and Sigal Fishman and Erwin Santo and Rainer Stengel and {De Jonge}, Charlotte and Greve, {Jan W.} and Cohen, {Ricardo V.} and Aboud, {Cristina M.} and Holtmann, {Gerald J.} and Graeme Rich and McMaster, {Jess J.} and Tadej Battelino and Primoz Kotnik and Byrne, {James P.} and Mason, {John C.} and Justin Bessell and Jeanine Bascomb and Lillian Kow and Janes Collins and Jacob Chisholm and Pferschy, {Peter N.} and Harald Sourij and Cull, {Melissa L.} and Wyres, {Melanie C.} and Russell Drummond and Barbara McGowan and Amiel, {Stephanie A.} and Mahi Yadagiri and Gupta, {Piya Sen} and Jens Aberle and Jochen Seufert",

note = "Funding Information: Funding. The ABCD provided funding to support the establishment of the ABCD World-wide EndoBarrier Registry. Duality of Interest. R.E.J.R. has received speaker fees, consultancy fees, and/or educational sponsorships from Abbott, BioQuest, GI Dynamics, and Novo Nordisk. J.S. and K.L. have received honoraria for speaker bureau, consultancy, and research funding from GI Dynamics. No other potential conflicts of interest relevant to this article were reported.",

year = "2023",

month = apr,

doi = "10.2337/dc22-1952",

language = "אנגלית",

volume = "46",

pages = "e89--e91",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "4",

}

Ryder, REJ, Laubner, K, Benes, M, Haluzik, M, Munro, L, Frydenberg, H, Teare, JP, Ruban, A, Fishman, S, Santo, E, Stengel, R, De Jonge, C, Greve, JW, Cohen, RV, Aboud, CM, Holtmann, GJ, Rich, G, McMaster, JJ, Battelino, T, Kotnik, P, Byrne, JP, Mason, JC, Bessell, J, Bascomb, J, Kow, L, Collins, J, Chisholm, J, Pferschy, PN, Sourij, H, Cull, ML, Wyres, MC, Drummond, R, McGowan, B, Amiel, SA, Yadagiri, M, Gupta, PS, Aberle, J & Seufert, J 2023, 'Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide', Diabetes Care, vol. 46, no. 4, pp. e89-e91. https://doi.org/10.2337/dc22-1952

TY - JOUR

T1 - Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity

T2 - Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

AU - Ryder, Robert E.J.

AU - Laubner, Katharina

AU - Benes, Marek

AU - Haluzik, Martin

AU - Munro, Lynne

AU - Frydenberg, Harry

AU - Teare, Julian P.

AU - Ruban, Aruchuna

AU - Fishman, Sigal

AU - Santo, Erwin

AU - Stengel, Rainer

AU - De Jonge, Charlotte

AU - Greve, Jan W.

AU - Cohen, Ricardo V.

AU - Aboud, Cristina M.

AU - Holtmann, Gerald J.

AU - Rich, Graeme

AU - McMaster, Jess J.

AU - Battelino, Tadej

AU - Kotnik, Primoz

AU - Byrne, James P.

AU - Mason, John C.

AU - Bessell, Justin

AU - Bascomb, Jeanine

AU - Kow, Lillian

AU - Collins, Janes

AU - Chisholm, Jacob

AU - Pferschy, Peter N.

AU - Sourij, Harald

AU - Cull, Melissa L.

AU - Wyres, Melanie C.

AU - Drummond, Russell

AU - McGowan, Barbara

AU - Amiel, Stephanie A.

AU - Yadagiri, Mahi

AU - Gupta, Piya Sen

AU - Aberle, Jens

AU - Seufert, Jochen

N1 - Funding Information: Funding. The ABCD provided funding to support the establishment of the ABCD World-wide EndoBarrier Registry. Duality of Interest. R.E.J.R. has received speaker fees, consultancy fees, and/or educational sponsorships from Abbott, BioQuest, GI Dynamics, and Novo Nordisk. J.S. and K.L. have received honoraria for speaker bureau, consultancy, and research funding from GI Dynamics. No other potential conflicts of interest relevant to this article were reported.

PY - 2023/4

Y1 - 2023/4

UR - http://www.scopus.com/inward/record.url?scp=85151043009&partnerID=8YFLogxK

U2 - 10.2337/dc22-1952

DO - 10.2337/dc22-1952

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 36716004

AN - SCOPUS:85151043009

SN - 1935-5548

VL - 46

SP - e89-e91

JO - Diabetes Care

JF - Diabetes Care

IS - 4

ER -

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

UN SDGs

Access to Document

Other files and links

Cite this